The latest announcements from Crassula Pharmaceuticals—science-driven breakthroughs, partnerships, and regulatory milestones. Assets and spokespeople are available for accredited media.
Crassula Pharmaceuticals Welcomes Crassula is thrilled to announce the appointment of Dr. Bhavana Gupta as its new Chief Technical Officer (CTO). Dr. Gupta will be at the forefront of managing the technical operations of the company, including overseeing the research and development department. Her role will also encompass serving as a vital technical advisor, directly reporting to Mr. Roopesh Gupta,
Cancer Remains A Threat In The Society Cancer is caused by disturbances in cell growth and behavior. In a healthy body, new white blood cells are regularly produced to replace old, dying blood cells. Blood cancer is caused by excessive production of white blood cells in the bone marrow. Why Is Cancer Still Growing?The biggest threats related to climate change
Noncommunicable diseases (NCDs) Tackling Noncommunicable Diseases: A Global Health Priority Noncommunicable diseases (NCDs), including cancer, heart disease, and diabetes, are among the most prevalent and rapidly escalating health issues facing society today. These conditions, characterized by their non-transmissible nature, contribute to approximately three-quarters of all global deaths, highlighting a significant public health challenge. Alarmingly, about 77% of NCD-related fatalities occur
Crassula Pharmaceuticals Launches in Honduras Crassula Pharmaceuticals Launches Gasflum, Esomeprazole 40mg Coated Tablet, in Honduras Tegucigalpa, Honduras – Crassula Honduras, a premier pharmaceutical manufacturer, proudly announces the launch of Gasflum, an esomeprazole 40mg coated tablet, enhancing its portfolio of high-quality healthcare solutions in Honduras. Designed for effective management of acid reflux and related conditions, Gasflum offers a significant advancement in